US Stock MarketDetailed Quotes
NGNE Neurogene
- 34.130
- -1.850-5.14%
Close Jul 5 16:00 ET
- 35.020
- +0.890+2.61%
Post 18:21 ET
443.02MMarket Cap-12051P/E (TTM)
35.865High33.670Low69.48KVolume35.780Open35.980Pre Close2.38MTurnover1.17%Turnover RatioLossP/E (Static)12.98MShares53.00052wk High2.59P/B203.11MFloat Cap12.20052wk Low--Dividend TTM5.95MShs Float1115.000Historical High--Div YieldTTM6.10%Amplitude7.500Historical Low34.300Avg Price1Lot Size
Neurogene Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 44.07%18.78M | -1.65%55.58M | 15.22M | -18.28%12.6M | 13.04M | 11.84%56.52M | 15.41M | 50.53M |
| Selling and administrative expenses | 90.33%5.24M | 24.16%11.19M | --3.61M | 1.52%2.28M | --2.75M | 8.97%9.01M | --2.24M | --8.27M |
| -General and administrative expense | 90.33%5.24M | 24.16%11.19M | --3.61M | 1.52%2.28M | --2.75M | 8.97%9.01M | --2.24M | --8.27M |
| Research and development costs | 31.68%13.54M | -6.55%44.39M | --11.61M | -21.65%10.32M | --10.28M | 12.40%47.51M | --13.17M | --42.26M |
| Operating profit | -44.07%-18.78M | 1.65%-55.58M | -15.22M | 18.28%-12.6M | -13.04M | -11.84%-56.52M | -15.41M | -50.53M |
| Net non-operating interest income expense | 198.97%2.32M | 120.15%2.94M | 646K | 337.87%740K | 775K | 7,752.94%1.34M | 169K | 17K |
| Non-operating interest income | 198.58%2.32M | 120.72%2.95M | --650K | 339.64%743K | --777K | 7,764.71%1.34M | --169K | --17K |
| Non-operating interest expense | 50.00%3K | 500.00%12K | --4K | --3K | --2K | --2K | --0 | --0 |
| Other net income (expense) | -15,200.00%-459K | 233,342.86%16.33M | -4K | -4K | -3K | -7K | ||
| Special income (charges) | ---- | --16.36M | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | ---- | ---16.36M | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non- operating income (expenses) | -15,200.00%-459K | -300.00%-28K | ---4K | ---4K | ---3K | ---7K | ---- | ---- |
| Income before tax | -37.98%-16.92M | 34.20%-36.32M | -14.58M | 22.20%-11.86M | -12.26M | -9.25%-55.19M | -15.25M | -50.52M |
| Income tax | ||||||||
| Net income | -37.98%-16.92M | 34.20%-36.32M | -14.58M | 22.20%-11.86M | -12.26M | -9.25%-55.19M | -15.25M | -50.52M |
| Net income continuous Operations | -37.98%-16.92M | 34.20%-36.32M | ---14.58M | 22.20%-11.86M | ---12.26M | -9.25%-55.19M | ---15.25M | ---50.52M |
| Minority interest income | ||||||||
| Net income attributable to the parent company | -37.98%-16.92M | 34.20%-36.32M | -14.58M | 22.20%-11.86M | -12.26M | -9.25%-55.19M | -15.25M | -50.52M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | -37.98%-16.92M | 34.20%-36.32M | -14.58M | 22.20%-11.86M | -12.26M | -9.25%-55.19M | -15.25M | -50.52M |
| Basic earnings per share | 87.97%-1 | -95.32%-73.835 | -9.88 | 22.20%-8.0367 | -8.3098 | -9.25%-37.8012 | -10.3305 | -34.6012 |
| Diluted earnings per share | 87.97%-1 | -95.32%-73.835 | -9.88 | 22.20%-8.0367 | -8.3098 | -9.25%-37.8012 | -10.3305 | -34.6012 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg